Skip to main content
. Author manuscript; available in PMC: 2013 Nov 21.
Published in final edited form as: J Am Chem Soc. 2012 Nov 13;134(46):18998–19003. doi: 10.1021/ja3057002

Table 1.

Cytotoxicitya and translation inhibition of psymberin, mycalamide and analogs against human tumor cell lines.b

Compound Cytotoxicity (IC50, nM) Translation Inhibition (EC50, nM)***
in vitro assay cell-based assay

Hela* SK-MEL-5** HeLa SK-MEL-5
Cycloheximide 2242±1515 3116±754 3150±2152 3325±834 2670
1a 0.64±0.14 0.27±0.04 28±7 2.2±1.4 11±10
1b 0.54±0.01 0.35±0.07 142±21 5.8±1.7 4.2±3.2
1c 2.34±0.53 1.58±0.42 120±47 9.6±8.9 9.3±8.5
8 2.52±1.39 3.79±0.04 238±44 59±32 64
3 618.6±267.0 352.0±12.1 346±64 4950±4870 496
4 >1000 762.8±70.0 318±182 2200±1410 843
5 >1000 >1000 641±262 1650±1060 578
6 >1000 >1000 >10000 >10000 >10000
7 >1000 >1000 >10000 >10000 >10000
a

A CellTiter-Glo® luminescent assay, which measures cellular ATP concentrations, was used to measure cell viability with and without compound treatment. IC50 values were calculated by fitting the luminescence data to an equation representing the dose-response of inhibiting luminescence.

b

Data are means ± standard deviation from at least two independent experiments conducted in triplicate.

*

R2 values range from 0.931 to 0.994.

**

R2 values range from 0.865 to 0.997.

***

R2 ranges from 0.90 to 0.995.